These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 24467717)

  • 21. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2022 Mar; 97(3):352-372. PubMed ID: 34985762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How I diagnose and treat chronic myelomonocytic leukemia.
    Patnaik MM
    Haematologica; 2022 Jul; 107(7):1503-1517. PubMed ID: 35236051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.
    Krishnamurthy P; Lim ZY; Nagi W; Kenyon M; Mijovic A; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Bone Marrow Transplant; 2010 Oct; 45(10):1502-7. PubMed ID: 20098454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
    Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
    Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the accuracy of prognostication in chronic myelomonocytic leukemia.
    Kaivers J; Schuler E; Hildebrandt B; Betz B; Rautenberg C; Haas R; Kobbe G; Gattermann N; Germing U
    Expert Rev Anticancer Ther; 2020 Aug; 20(8):703-714. PubMed ID: 32700646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment advances for pediatric and adult onset neoplasms with monocytosis.
    McCullough KB; Kuhn AK; Patnaik MM
    Curr Hematol Malig Rep; 2021 Jun; 16(3):256-266. PubMed ID: 33728588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic myelomonocytic leukemia: from diagnosis to treatment].
    Hafraoui K; De Prijck B; Beguin Y
    Rev Med Suisse; 2013 Aug; 9(395):1512, 1514-7. PubMed ID: 24024420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
    Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
    Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How I treat chronic myelomonocytic leukemia.
    Solary E; Itzykson R
    Blood; 2017 Jul; 130(2):126-136. PubMed ID: 28572287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
    Gelsi-Boyer V; Trouplin V; Roquain J; Adélaïde J; Carbuccia N; Esterni B; Finetti P; Murati A; Arnoulet C; Zerazhi H; Fezoui H; Tadrist Z; Nezri M; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D
    Br J Haematol; 2010 Nov; 151(4):365-75. PubMed ID: 20880116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel therapeutic targets for chronic myelomonocytic leukemia.
    Lasho T; Patnaik MM
    Best Pract Res Clin Haematol; 2021 Mar; 34(1):101244. PubMed ID: 33762099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic myelomonocytic leukemia: lost in classification?
    Bowen DT
    Hematol Oncol; 2005 Mar; 23(1):26-33. PubMed ID: 16149105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia].
    Zhang XH; Zhou JY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):18-21. PubMed ID: 38527833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia.
    Rezazadeh A; Deininger M; Atallah E
    Curr Treat Options Oncol; 2023 Aug; 24(8):1036-1051. PubMed ID: 37300657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary treatment approaches to CMML - Is allogeneic HCT the only cure?
    Robin M; Itzykson R
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101138. PubMed ID: 32460980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia.
    Lewis DJ; Miranda RN; Oh CW; Hinojosa T; Medeiros LJ; Curry JL; Tetzlaff MT; Torres-Cabala CA; Nagarajan P; Ravandi-Kashani F; Duvic M
    Clin Exp Dermatol; 2018 Jun; 43(4):449-453. PubMed ID: 29423961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of allogeneic HST for chronic myelomonocytic leukemia.
    Cheng H; Kirtani VG; Gergis U
    Bone Marrow Transplant; 2012 Apr; 47(4):535-41. PubMed ID: 21743499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
    Park S; Labopin M; Yakoub-Agha I; Delaunay J; Dhedin N; Deconinck E; Michallet M; Robin M; De Revel T; Bernard M; Vey N; Lioure B; Lapusan S; Tabrizi R; Bourhis JH; Huynh A; Beguin Y; Socié G; Dreyfus F; Fenaux P; Mohty M
    Eur J Haematol; 2013 May; 90(5):355-64. PubMed ID: 23320648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CMML: a biologically distinct myeloproliferative disease.
    Cortes J
    Curr Hematol Rep; 2003 May; 2(3):202-8. PubMed ID: 12901341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.